Theravance, Inc. (NASDAQ:THRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

Recs

0
Player Avatar star60629 (< 20) Submitted: 4/30/2007 8:58:01 PM : Underperform Start Price: $32.86 THRX Score: +27.08

Easiest way to find overvalued stocks go thru some biotechs.This one way overpriced Rev 20 Mil shares 60 mil. Insiders selling.Book value $1 . Muahhh look out below.My biotech shorts are outperforming. Get a basket of the worst ones and short.

Featured Broker Partners


Advertisement